Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -33.33% vs 200.00% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -1.60% vs 59.55% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 27.34% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -4.55% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of BioXcel Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -33.33% vs 200.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs -66.67% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -1.60% vs 59.55% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -73.97% vs 72.76% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 27.34% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -3.06% vs 59.00% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -4.55% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.00% vs 11.11% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






